Gamida Cell
Gamida Cell
Biotechnology company developing potentially curative cell therapies for cancer patients.
About
Gamida Cell is a clinical-stage biopharmaceutical company focused on developing potentially curative cell therapies for patients with hematologic malignancies and solid tumors. Their proprietary NAM technology expands the number of cells while maintaining their intrinsic properties, aiming to create more effective and accessible cell therapies.
Key facts
- Website
- gamida-cell.com
- Headquarters
- Boston, United States
- Founded
- 1998
- Total funding
- $297M (Post-IPO)
- Valuation
- Private
- Business model
- B2B
- Tags
- Life SciencesBiotechMedTechHealthTechDrug Discovery
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 27 Mar 2024 | Post-IPO | $30M | - | Highbridge Capital |
| 21 Apr 2023 | Post-IPO | $23M | - | - |
| 16 Feb 2021 | Post-IPO | $75M | $75M | Highbridge Capital |
| 1 Jul 2019 | Post-IPO | $35M | - | - |
| 19 Jun 2017 | Series G | $40M | $160M | Shavit Capital |
| 15 Oct 2015 | Series F | $5M | $200M | Novartis Venture Fund |
| 19 Aug 2014 | Series F | $35M | $233M | Novartis Venture Fund |
| 15 May 2012 | Series E | $10M | - | - |
| 20 Jan 2006 | Series D | $16M | - | Israel Healthcare Ventures |
| 12 Mar 2003 | Series C | $3M | - | Teva |
| 30 Sept 2001 | Series B | $16M | $36M | - |
| 20 Feb 2000 | Series A | $7M | $14M | Elscint BioMedical |
Tech stack
Detected on gamida-cell.com, last scanned 19 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Mimecast
- Cookie consent
- Termly
Add first review
Frequently asked
How much funding has Gamida Cell raised?
Gamida Cell has raised a total of $297M in funding. The most recent round on record is Post-IPO.